DOCPLANET COM INC
SC 13D, 2000-08-23
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: LIBERTY GROUP HOLDINGS INC, 10QSB, EX-27.1, 2000-08-23
Next: DOCPLANET COM INC, SC 13D, EX-1, 2000-08-23



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON,  D.C.  20549

                                  SCHEDULE  13D/A

                 UNDER  THE  SECURITIES  EXCHANGE  ACT  OF  1934*
                                (AMENDMENT NO. 7)

                               DOCPLANET.COM,  INC.
                                (NAME  OF  ISSUER)

                           COMMON STOCK, NO PAR VALUE
                      (TITLE  OF  CLASS  OF  SECURITIES)


                                  (CUSIP  NUMBER)

               CHARLES  R.  DRUMMOND                         Copies  to
               3000  W.  WARNER  AVENUE                      ----------
         SANTA  ANA,  CALIFORNIA  92704-5311           THOMPSON  KNIGHT  BROWN
                  (714)  754-5800                      PARKER &  LEAHY  L.L.P.
                                                      1200  SMITH,  SUITE  3600
                                                         HOUSTON,  TX  77002
                                                        ATTN:  DALLAS  PARKER
                                                           (713)  654-8111
(NAME,  ADDRESS  AND  TELEPHONE  NUMBER  OF  PERSON
AUTHORIZED  TO  RECEIVE  NOTICES  AND  COMMUNICATIONS)


                                   MARCH  14,  2000
                    (DATE  OF  EVENT  WHICH  REQUIRES  FILING
                                 OF  THIS  STATEMENT)

If  the filing person has previously filed a statement on Schedule 13G to report
the  acquisition  which  is the subject of this Schedule 13D, and is filing this
schedule  because  of    240.13d-1(e),  240.13d-1(f)  or 204.13d-1(g), check the
following  box.  [  ]

NOTE:  Schedules  filed in paper format shall include a signed original and five
copies  of  the  schedule, including all exhibits.  See   240.13d-7(b) for other
parties  to  whom  copies  are  to  be  sent.

*The  remainder  of  the cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent  amendment  containing  information  which  would  alter
disclosures  provided  in  a  prior  cover  page.

The information required on the remainder of this cover page shall not be deemed
to  be  "filed"  for the purpose of Section 18 of the Securities Exchange Act of
1934  ("Act") or otherwise subject to the liabilities of that section of the Act
but  shall  be  subject  to  all  other  provisions of the Act (however, see the
Notes).


<PAGE>
CUSIP  NO.                      SCHEDULE  13D/A

(1)  Names  of Reporting Persons, I.R.S. Identification Nos. of Above Persons

          CHARLES  R.  DRUMMOND
--------------------------------------------------------------------------------

(2)  Check the Appropriate Box if a Member of a Group (See Instructions)
                                                                         (a) [_]
                                                                         (b) [_]
--------------------------------------------------------------------------------
(3)  SEC  Use  Only

--------------------------------------------------------------------------------

(4)  Source  of  Funds  (See  Instructions)                                  OO*

--------------------------------------------------------------------------------

(5)  Check  if  Disclosure of Legal Proceedings is Required Pursuant to
     Items 2(d) or  2(e)                                                     [_]

--------------------------------------------------------------------------------

(6)  Citizenship  or  Place  of  Organization                     UNITED  STATES

--------------------------------------------------------------------------------

Number of                            (7) Sole  Voting  Power           1,000,000
                                     -------------------------------------------
Shares Benficially                   (8) Shared  Voting  Power       1,230,640**
                                     -------------------------------------------
Owned by Each                        (9) Sole Dispositive Power        1,000,000
                                     -------------------------------------------
Reporting Person With                (10) Shared Dispositive Power   1,230,640**
--------------------------------------------------------------------------------

(11) Aggregate Amount Beneficially Owned by Each Reporting Person
                                                                       2,230,640

--------------------------------------------------------------------------------

(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares
     (See Instructions)                                                      [_]

--------------------------------------------------------------------------------

(13) Percent  of  Class  Represented  by  Amount  in  Row  (11)            29.7%

--------------------------------------------------------------------------------

(14) Type  of  Reporting  Person  (See  Instructions)                         IN

--------------------------------------------------------------------------------


* received as a gift
**  Mr.  Drummond  is one of three partners in Drummond Land and Cattle Company,
an  Oklahoma  general  partnership  ("DLCC"),  of  which  he owns and has voting
control  over  33.3%.   DLCC  owns  1,230,640  shares  of  Common  Stock  of the
Company.  As  such, voting and dispositive power for such Common Stock is shared
equally  between  the  partners  of  DLCC.


                                     Page 2
<PAGE>
                            AMENDMENT TO SCHEDULE 13D

     This  Amendment No. 7 to Schedule 13D (this "Amendment") is filed on behalf
of  Charles  R.  Drummond with respect to his beneficial ownership of the common
stock  of  DocPlanet.com,  Inc. (formerly named docsales.com, Inc., whose former
name  was  Golden  Pharmaceuticals, Inc., whose former name was Benedict Nuclear
Pharmaceuticals,  Inc.).

     This  Amendment amends in its entirety the Schedule 13D previously filed by
Charles R. Drummond on March 12, 1991, as amended by Amendment Nos. 1 through 6.


ITEM  1.  SECURITY  AND  ISSUER.

     This  statement  relates  to shares of common stock, no par value per share
(the  "Common  Stock"),  of  DocPlanet.com, Inc. (the "Company").  The Company's
principal  executive  office  is  located  at  3000 W. Warner Avenue, Santa Ana,
California  92704-5311.

ITEM  2.  IDENTITY  AND  BACKGROUND.

     This  statement  is  being  filed  on  behalf  of Charles R. Drummond ("Mr.
Drummond").  Mr.  Drummond's  principal  occupation  or  employment is to act as
Chairman,  Chief  Executive  Officer  and  Treasurer  of  the  Company,  and his
principal  business  address  is  3000  W.  Warner Avenue, Santa Ana, California
92704-5311.

     Mr.  Drummond  has  not,  during  the  last five years, been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors).  Mr.
Drummond has not, during the last five years, been a party to a civil proceeding
of  a  judicial or administrative body of competent jurisdiction and as a result
of  such  proceeding  was  or  is  subject  to a judgment, decree or final order
enjoining  further  violations of, or prohibiting activities subject to, federal
or  state  securities  laws  or  finding  any  violation  of  such  laws.

     Mr.  Drummond  is  a  citizen  of  the  United  States.

ITEM  3.  SOURCE  AND  AMOUNT  OF  FUNDS  OR  OTHER  CONSIDERATION.

     On  March 14, 2000, Mr. Drummond gave 2,157,400 shares of Common Stock as a
gift  to  certain  family  members  and  a  family  owned  business.

ITEM  4.  PURPOSE  OF  TRANSACTION.

     On  different  occasions,  Mr.  Drummond  has entered into discussions that
could  result  in a sale of all or a portion of the shares of Common Stock owned
by  him  which  may  lead to a material change in the management of the Company.

     Except  as  stated  above,  Mr. Drummond currently has no plan, proposal or
intention which relates to, or would result in, any of the actions enumerated in
Item  4  of  the  instructions  to  Schedule  13D.


ITEM  5.  INTEREST  IN  SECURITIES  OF  THE  ISSUER.

     As of the date hereof, Mr. Drummond is the direct owner of 1,000,000 shares
of  the  Common Stock of the Company and  may be deemed to be a beneficial owner
of  1,230,640  additional  shares  through DLCC, of which he owns and has voting
control over 33.3%.  As of the date hereof, there are 7,521,311 shares of Common
Stock  outstanding,  and  on such basis, Mr. Drummond beneficially owns 29.7% of
the  Company's  outstanding  shares  of Common Stock.  Mr. Drummond has the sole
power  to  vote,  direct  the  vote, dispose of or direct the disposition of all
shares  of  the  Company's  Common  Stock  that he currently directly owns.  Mr.
Drummond  also  shares  the power to vote, direct the vote, dispose of or direct
the disposition of the shares of the Company's Common Stock that he beneficially
owns through DLCC.  The information required by Item 2 with respect to the other
partners of DLCC is provided  in  Exhibit  1  attached  hereto.

     Except  as  otherwise  described  herein, Mr. Drummond has not effected any
transaction  in  shares  of  Common  Stock  during  the  past  60  days.


                                     Page 3
<PAGE>
ITEM  6.  CONTRACTS,  ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
          TO  THE  SECURITIES  OF  THE  ISSUER.

     Mr.  Drummond  has  no contract, arrangement, understanding or relationship
with  any  person  with  respect  to  the  Common  Stock  of  the  Company.

ITEM  7.  MATERIAL  TO  BE  FILED  AS  EXHIBITS.

     Exhibit  1 is  being  filed  with  this  statement.


                                     Page 4
<PAGE>
                                   SIGNATURES


     After  reasonable  inquiry  and  to  the best of my knowledge and belief, I
certify  that  the information set forth in this statement is true, complete and
correct.



Date:  August  21,  2000



By:  /s/  Charles  R.  Drummond
   ----------------------------


                                     Page 5
<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission